141 related articles for article (PubMed ID: 33459027)
1. Duration of Hyperemia With Intracoronary Administration of Papaverine.
Mizukami T; Sonck J; Gallinoro E; Kodeboina M; Canvedra A; Nagumo S; Bartunek J; Wyffels E; Vanderheyden M; Shinke T; De Bruyne B; Collet C
J Am Heart Assoc; 2021 Feb; 10(3):e018562. PubMed ID: 33459027
[No Abstract] [Full Text] [Related]
2. Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine.
Nakayama M; Tanaka N; Yamashita J; Iwasaki K
Cardiovasc Interv Ther; 2020 Oct; 35(4):371-378. PubMed ID: 31939068
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M
Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
[TBL] [Abstract][Full Text] [Related]
5. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
[TBL] [Abstract][Full Text] [Related]
6. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
8. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
Aarnoudse W; Geven M; Barbato E; Botman KJ; De Bruyne B; Pijls NH
Am J Cardiol; 2005 Dec; 96(12):1627-30. PubMed ID: 16360347
[TBL] [Abstract][Full Text] [Related]
9. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
Murtagh B; Higano S; Lennon R; Mathew V; Holmes DR; Lerman A
Am Heart J; 2003 Jul; 146(1):99-105. PubMed ID: 12851614
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter.
Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M
Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819
[TBL] [Abstract][Full Text] [Related]
11. Effect of QTU prolongation on hyperemic instantaneous wave-free ratio value: a prospective single-center study.
Nakayama M; Uchiyama T; Hijikata N; Kobori Y; Tanaka N; Iwasaki K
Heart Vessels; 2020 Jul; 35(7):909-917. PubMed ID: 31989184
[TBL] [Abstract][Full Text] [Related]
12. ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation.
Jain RK; Chitnis NS; Hygriv Rao B
Indian Heart J; 2014; 66(3):289-93. PubMed ID: 24973833
[TBL] [Abstract][Full Text] [Related]
13. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced Hyperemia as an Alternative to Drug-induced Hyperemia in the Evaluation of the Fractional Flow Reserve in Coronary Lesions.
Shiode N; Okimoto T; Tamekiyo H; Kawase T; Yamane K; Kagawa Y; Fujii Y; Ueda Y; Hironobe N; Kato Y; Hayashi Y
Intern Med; 2017; 56(3):253-257. PubMed ID: 28154267
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve.
Chhabria R; Mehta NP; Jain N; Handa SR; Mehta AB
Indian Heart J; 2020; 72(6):603-605. PubMed ID: 33357653
[TBL] [Abstract][Full Text] [Related]
16. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
[TBL] [Abstract][Full Text] [Related]
18. [A novel way to induce coronary hyperaemia].
Tkaczewski K; Dziuk M; Kocki J; Pińkowski R
Postepy Hig Med Dosw (Online); 2013 Sep; 67():933-7. PubMed ID: 24088536
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: case series and literature review.
Patel HR; Shah P; Bajaj S; Virk H; Bikkina M; Shamoon F
Cardiovasc Interv Ther; 2017 Oct; 32(4):374-380. PubMed ID: 27577946
[TBL] [Abstract][Full Text] [Related]
20. Fractional Flow Reserve in the Transradial Era: Will Hand Vein Adenosine Infusion Suffice?: A Comparative Study of the Extent, Rapidity, and Stability of Hyperemia From Hand and Femoral Venous Routes of Adenosine Administration.
Scott P; Sirker A; Dworakowski R; Paul G; Candilio L; Jahagirdar N; Melikian N; Byrne J
JACC Cardiovasc Interv; 2015 Apr; 8(4):527-35. PubMed ID: 25819188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
